Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2025 08:45 ET | Source: Autonomix Medical, Inc.

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

Follow-on study (“PoC 2”) builds on initial success in pancreatic cancer pain Ethics committee authorization supports platform expansion into visceral cancer pain for proprietary ablation technology...
June 10, 2024 08:00 ET | Source: Autonomix Medical, Inc.

Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024

Management to host live webcast to discuss results on Tuesday, June 18th at 8:30 a.m. ET THE WOODLANDS, TX, June 10, 2024 (GLOBE NEWSWIRE) -- – Autonomix Medical, Inc. (NASDAQ: AMIX)...
February 22, 2024 08:00 ET | Source: Autonomix Medical, Inc.

Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study

Proof-of-concept (PoC) human clinical trial targeting multi-billion-dollar pancreatic cancer market through transvascular RF ablation Company expects to commence patient enrollment imminently...
August 06, 2019 13:00 ET | Source: Société canadienne du sang

Sécurisation de l’approvisionnement en plasma du Canada

OTTAWA, 06 août 2019 (GLOBE NEWSWIRE) -- La Société canadienne du sang a le plaisir d’annoncer qu’avec le soutien de ses bailleurs de fonds, elle a entrepris d’augmenter la quantité de plasma...
August 06, 2019 13:00 ET | Source: Canadian Blood Services

Securing Canada’s plasma supply

OTTAWA, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Canadian Blood Services is pleased to announce that with the support of funding governments, plans are now underway to increase plasma collection with three...
November 14, 2018 07:00 ET | Source: Provectus Biopharmaceuticals Inc.

PROVECTUS BIOPHARMACEUTICALS PROVIDES DRUG DEVELOPMENT UPDATE FOR IMMUNO-DERMATOLOGY ASSET PH-10

KNOXVILLE, TN, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided an update on the Company’s small molecule clinical development program for its investigational...
July 18, 2018 09:00 ET | Source: GrowLife, Inc.

GrowLife, Inc. Announces 4x Increase in Production Capacity from 15 to 70 Plants Using its Proprietary Vertical Grow Room

KIRKLAND, Wash., July 18, 2018 (GLOBE NEWSWIRE) -- GrowLife, Inc. (OTCQB:PHOT), one of the nation’s most recognized indoor cultivation product and service providers, today announced preliminary test...